DA agonists -- ergot derivatives: dihydroergocryptine (DHEC): management of Parkinson's disease.
出版信息
Mov Disord. 2002;17 Suppl 4:S72-3. doi: 10.1002/mds.5564.
DOI:10.1002/mds.5564
PMID:12211143
Abstract
摘要
相似文献
1
DA agonists -- ergot derivatives: dihydroergocryptine (DHEC): management of Parkinson's disease.
Mov Disord. 2002;17 Suppl 4:S72-3. doi: 10.1002/mds.5564.
2
DA agonists -- ergot derivatives: pergolide: management of Parkinson's disease.
Mov Disord. 2002;17 Suppl 4:S79-82. doi: 10.1002/mds.5566.
3
DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease.
Mov Disord. 2002;17 Suppl 4:S74-8. doi: 10.1002/mds.5565.
4
DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
Mov Disord. 2002;17 Suppl 4:S53-67. doi: 10.1002/mds.5562.
5
DA agonists -- ergot derivatives: cabergoline: management of Parkinson's disease.
Mov Disord. 2002;17 Suppl 4:S68-71. doi: 10.1002/mds.5563.
6
DA agonists -- non-ergot derivatives: ropinirole: management of Parkinson's disease.
Mov Disord. 2002;17 Suppl 4:S98-102. doi: 10.1002/mds.5570.
7
DA agonists -- non-ergot derivatives: piribedil: management of Parkinson's disease.
Mov Disord. 2002;17 Suppl 4:S90-2. doi: 10.1002/mds.5568.
8
Dihydroergocryptine in the treatment of Parkinson's disease.
J Neural Transm Suppl. 1995;45:239-45.
9
DA agonists -- non-ergot derivatives: pramipexole: management of Parkinson's disease.
Mov Disord. 2002;17 Suppl 4:S93-7. doi: 10.1002/mds.5569.
10
DA agonists -- non-ergot derivatives: apomorphine: management of Parkinson's disease.
Mov Disord. 2002;17 Suppl 4:S83-9. doi: 10.1002/mds.5567.
Zotero 插件